Antiretroviral therapy is not curative. Given the challenges in providing lifelong therapy to a
global population of more than 35 million people living with HIV, there is intense interest in …

Introduction: The search for an HIV cure involves important behavioural and social
processes that complement the domains of biomedicine. However, the field has yet to tap …

Though antiretroviral therapy is the standard of care for people living with HIV, its treatment
limitations, burdens, stigma and costs lead to continued interest in HIV cure research. Early …

Introduction Biomedical research towards an HIV cure is advancing in the United States and
elsewhere, yet little is known about perceptions of risks and benefits among potential study …

The quest for a cure for HIV remains a timely and key challenge for the HIV research
community. Despite significant scientific advances, current HIV therapy regimens do not …

Clinical and basic science advances have raised considerable hope for achieving an HIV
cure by accelerating research. This research is dominated primarily by issues about the …

Currently, much of early phase HIV cure research involves unknown and potentially serious
risks, with little or no chance of direct health benefits. During informed consent, researchers …

Current HIV therapy is not curative regardless of how soon after infection it is initiated or how
long it is administered, and therapy interruption almost invariably results in robust viral …

Early-phase HIV cure research is conducted against a background of highly effective
antiretroviral therapy, and involves risky interventions in individuals who enjoy an almost …

Context Despite huge advances in the fight against HIV concerning diagnosis, clinical
efficacy of antiretroviral treatments (ART), patient survival and quality of life, there is still no …